Journal of Clinical Oncology (JCO) Podcast

29

The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice.The JCO Podcast also features in depth summaries and interviews hosted by the year’s fellows in the series, JCO Article Insights.

Recent Episodes
  • Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment
    Apr 10, 2025 – 26:50
  • JCO Article Insights: Smoking Assessment
    Mar 31, 2025 – 08:35
  • Botensilimab Plus Balstilimab in Advanced Sarcomas
    Mar 13, 2025 – 21:00
  • JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer
    Feb 24, 2025 – 08:47
  • High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer
    Feb 13, 2025 – 12:12
  • JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC
    Jan 27, 2025 – 10:21
  • Air Pollution and Breast Cancer Incidence
    Jan 9, 2025 – 25:43
  • JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing
    Dec 30, 2024 – 09:01
  • Overcoming Barriers to Make Patient-Partnered Research a Reality
    Dec 12, 2024 – 34:38
  • JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma
    Nov 25, 2024 – 09:42
  • Quality of Treatment Selection
    Nov 14, 2024 – 25:05
  • JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy
    Oct 28, 2024 – 09:52
  • Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer
    Oct 16, 2024 – 16:40
  • Combining Response and Toxicity Data to Implement Project Optimus
    Sep 30, 2024 – 23:55
  • CBT-I for Cancer-Related Cognitive Impairment
    Sep 12, 2024 – 31:21
  • JCO Article Insights: Assisted Reproduction in Breast Cancer Patients
    Aug 26, 2024 – 22:48
  • Multi-Cancer Early Detection Testing for High-Risk Patients
    Aug 8, 2024 – 30:29
  • JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
    Jul 29, 2024 – 17:27
  • Functional Disability Among US Cancer Survivors
    Jul 11, 2024 – 16:12
  • CAR T-Cell Therapy for Richter’s Transformation
    Jun 24, 2024 – 09:19
  • EAZ171: Predictors of TIPN in Black Women with Breast Cancer
    Jun 3, 2024 – 14:38
  • JCO Article Insights: Final Analysis of the Ro-CHOP Trial
    May 27, 2024 – 08:49
  • Methylphenidate for Fatigue in Advanced Cancer
    May 17, 2024 – 20:16
  • Introducing JCO Oncology Advances with Dr. Jonathan Friedberg and Dr. Pamela Kunz
    May 9, 2024 – 16:36
  • JCO Article Insights: Atezolizumab Plus Bevacizumab, Chemotherapy in EGFR, ALK NSCLC
    Apr 29, 2024 – 11:29
  • Commonly Held Beliefs About Cancer Survivorship
    Apr 11, 2024 – 17:37
  • JCO Article Insights: Long Term Follow Up of the RESORT (E4402) and LYSA Study
    Mar 25, 2024 – 10:05
  • Pembrolizumab in Patients With Advanced Cancers With HTMB
    Mar 14, 2024 – 19:56
  • JCO Article Insights: Axillary Soft Tissue Involvement and Breast Cancer Prognosis
    Feb 26, 2024 – 08:31
  • Omission of Radiotherapy after Breast-Conserving Surgery
    Feb 22, 2024 – 20:42
  • Costs of Cancer Prevention in CDH1 Variant Carriers
    Feb 8, 2024 – 23:33
  • JCO Article Insights: Low and Moderate Grade Adverse Events and the Patient Experience in Clinical Trials
    Jan 29, 2024 – 09:50
  • Debunking Sex and Disentangling Gender From Oncology
    Jan 25, 2024 – 23:09
  • Germline EGFR Mutations and Familial Lung Cancer
    Jan 11, 2024 – 18:08
  • JCO Article Insights: DYPD-Guided Dose Individualization and Survival Outcomes
    Jan 4, 2024 – 20:40
  • Negative Impact of Prior Authorization on Patients with Cancer
    Dec 14, 2023 – 18:19
  • Role of Molecular Classification in Predicting Response to Radiation in Early Endometrial Cancer
    Nov 30, 2023 – 23:06
  • JCO Article Insights: Impact of Physical Activity on Mortality and of BMI on Treatment-Related Adverse Events
    Nov 27, 2023 – 11:39
  • Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
    Nov 5, 2023 – 23:23
  • JCO Article Insights: Safety and efficacy of a Novel ADC Targeting TROP-2 in Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Oct 30, 2023 – 27:37
  • Economic Evaluation of a Non-Medical Financial Assistance Program on Missed Treatment Appointments Among Adults With Cancer
    Oct 28, 2023 – 24:24
  • Disparities in End-of-Life Cancer Care
    Oct 12, 2023 – 26:01
  • Advance Care Planning in Adolescents and Young Adults with Cancer
    Sep 28, 2023 – 22:13
  • JCO Article Insights: Improving Lung Cancer Screening Using Blood-Based Biomarkers
    Sep 25, 2023 – 07:50
  • Impact of Smoking Cessation on Mortality From Kidney Cancer
    Sep 14, 2023 – 29:37
  • HER3-DXd in EGFR-Mutated NSCLC: HERTHENA-Lung01
    Sep 10, 2023 – 16:22
  • JCO Article Insights: Introducing The Childhood Cancer Data Initiative
    Aug 28, 2023 – 18:41
  • Impact of Heatwaves on the Care of Patients With Cancer
    Aug 2, 2023 – 20:31
  • JCO Article Insights: Immunotherapy in People Living with HIV and Cancer
    Jul 21, 2023 – 25:14
  • Racial/Ethnic Differences Discovered in Multigene Germline Testing of Early-Onset Colorectal Cancer
    Jul 13, 2023 – 14:45
Recent Reviews
  • Jtn2
    Good Information, but
    The information provided is important, but the presenters are stilted.
  • Zoirusha
    I really want to like this podcast, but...
    unfortunately, although the content is excellent, the delivery is awful. Most of the time the presenters just read the text of the podcast - very fast, in a monotonous voice. While as a written piece it could perhaps work, it doesn't work as an audio. I end up pausing and rewinding, and eventually giving up on learning and remembering. An audio lecture needs to be delivered at a slower pace, with fewer lists and numbers...
  • Gazelle73
    Nice
    Good platform
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.